Biem Pharmaceuticals was founded in 1990 with headquarters in Ankara. It is a privately held pharmaceutical company engaged in manufacturing, distribution and marketing of pharmaceutical and healthcare products.
The company offers a high value pharmaceutical products portfolio on the Turkish and global market, at the same time pursuing partnerships with international leading pharmaceutical companies interested to enter on the Turkish domestic pharmaceutical market.
"Our success is an outcome of strategic focus on the pharmaceutical industry, constantly investing and promoting growth and innovation. Over the years, Biem Pharmaceuticals has extended its footprint beyond Turkey and other countries across the globe.
Our expertise lies in manufacturing and licensing of pharmaceutical products, Biem being well positioned to efficiently license, register and commercialize pharmaceutical products in Turkey, and abroad through its international partners," claims Biem.
The company’s main focus lies within the research and development of differentiated products in a wide range of therapeutic areas: oncology, hematology, radiology, transplantology, ophthalmology and gynecology.
LATEST issue 4/2018